Description: PsyBio Therapeutics Corp., a biotechnology company, develops formulations of psychoactive medications produced by genetically modified bacteria for the treatment of mental health and other disorders. It also engages in the research and development of naturally occurring tryptamines found in varieties of mushrooms, other tryptamines, and phenethylamines; and new molecular structures that do not occur in nature, as well as have therapeutics properties. PsyBio Therapeutics Corp. is headquartered in Coconut Creek, Florida.
Home Page: www.psybiolife.com
4400 West Sample Road
Coconut Creek,
FL
33073
United States
Phone:
513 449 9585
Officers
| Name | Title |
|---|---|
| Mr. Evan Mike Levine | Co-Founder, CEO & Chairman |
| Mr. Noah Isidore Davis | CFO, Sec. & Director |
| Dr. Michael Spigarelli M.B.A., M.B.E., M.D., Ph.D. | Chief Scientific Officer & Chief Medical Officer |
| Mr. Ross Carmel | Chief Legal Officer & Director |
| Mr. Andrew Jones | Inventor & Chairman of Scientific Advisory Board |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 202.4228 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 4 |